You are here
Biomedical Frontiers, Inc.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
MACROMOLECULAR CONTRAST AGENTS FOR MAGNETIC RESONANCE
Amount: $675,000.00BIOMEDICAL FRONTIERS (BMF) HAS ESTABLISHED THAT THE IRON CHELATOR, DEFEROXAMINE, CAN BE COVALENTLY BOUND TO POLYMERS AND HAS DEMONSTRATED, IN PRECLINICAL STUDIES, THAT THESE CONJUGATES CAN BE USED THE ...
SBIRPhase II1994Department of Health and Human Services -
Tumor Growth Inhibition by Iron Deprivation
Amount: $80,250.00This research will determine the potential utility of novel high molecular weight iron chelatorsas anti-cancer agents or adjuncts to other iron-depriving therapeutic strategies in the treatment ofcanc ...
SBIRPhase I1994Department of Health and Human Services -
MACROMOLECULAR CONTRAST AGENTS FOR MAGNETIC RESONANCE
Amount: $50,000.00N/A
SBIRPhase I1991Department of Health and Human Services -
SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON CHELATORS
Amount: $249,000.00IN CHEMICAL AND BIOLOGICAL SYSTEMS, IRON IS BOTH UBIQUITOUS AND HIGHLY REACTIVE. IN A VARIETY OF CIRCUMSTANCES, THERE IS GREAT NEED FOR NEW APPROACHES TO THE REMOVAL OF IRON OR THE CONTROL OF ITS REAC ...
SBIRPhase II1987Department of Health and Human Services -
SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON CHELATORS
Amount: $44,000.00N/A
SBIRPhase I1986Department of Health and Human Services